Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000035209 | SCV000058853 | likely benign | not specified | 2009-08-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000872049 | SCV001013802 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000035209 | SCV001572464 | likely benign | not specified | 2021-04-08 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002504871 | SCV002813768 | likely benign | Ectopia lentis 1, isolated, autosomal dominant; Marfan syndrome; MASS syndrome; Stiff skin syndrome; Weill-Marchesani syndrome 2, dominant; Acromicric dysplasia; Geleophysic dysplasia 2; Progeroid and marfanoid aspect-lipodystrophy syndrome | 2021-07-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003162297 | SCV003911066 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-02-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |